SEARCH

SEARCH BY CITATION

References

  • 1
    Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 4163.
  • 2
    Martell M, Esteban JI, Quer J, Genescá J, Weiner A, Esteban R, Guardia J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 32253229.
  • 3
    Nousbaum J-B, Pol S, Nalpas B, Landais P, Bethelot P, Bréchot C, and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 4
    Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995; 22: 700706.
  • 5
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. Hepatology 1995; 222: 10501056.
  • 6
    Conjeevaram HC, Everhart JE, Hoofnagle JH. Predictors of a sustained biochemical response to interferon alpha therapy in chronic hepatitis C. Hepatology 1995; 22: 13261329.
  • 7
    Enomoto E, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism. J Gen Virol 1994; 75: 13611369.
  • 8
    Enomoto E, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995; 96: 224230.
  • 9
    Enomoto E, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 7781.
  • 10
    Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyamo Y, Koike H, et al. Pretreatment virus load and multiple amino acid substitutions in the Interferon Sensitivity Determining Region predict outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 1997; 25: 745749.
  • 11
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina I, Yamamoto C, Takaaki I, et al. Analysis of genotypes and amino acid residues 2209–2248 of the NS5A region of hepatitis C virus in relation to the response to interferon beta therapy. Hepatology 1997; 25: 750753.
  • 12
    Zeuzem S, Lee J-H, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon-α. Hepatology 1997; 25: 740744.
  • 13
    Halimi G, Halfon P, Gérolami V, Castets F, Khiri H, Bouliere M, Gauthier AP, et al. Mutations in the NS5A region and et interferon response in hepatitis 1b infected patients [Abstract]. Hepatology 1996; 24: 162A.
  • 14
    Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, et al. HCV NS5A mutations and response of chronic hepatitis to alpha interferon [Abstract]. Hepatology 1996; 24: 155A.
  • 15
    Murakami T, Enomoto N, Asahina Y, Izumi N, Maurmo F, Sato C. Mutations in NS5A region and response to interferon in HCV genotype 2 infections [Abstract]. Hepatology 1996; 24: 155A.
  • 16
    Niiyama G, Kimura T, Mitani K, Tsugeno H, Sengoku N, Kinoyama S, Ito T, et al. Mutations in the nonstructural protein 5A gene in chronic hepatitis C virus 1b infection patients with interferon treatment [Abstract]. Hepatology 1996; 24: 164A.
  • 17
    Iino S, Hino K, Kuroki T, Suzuki H, Yamamoto S. Treatment of chronic hepatitis C with high-dose interferon α−2b. A multicenter study. Dig Dis Sci 1993; 38: 612618.
  • 18
    Takada A, Tsutsumi M, Okanoue T, Matsushima T, Komatsu M, Fujiyama S. Distribution of the different subtypes of hepatitis C virus in Japan and the effects of interferon: a nationwide survey. J Gastro Heptol 1996; 11: 201207.
  • 19
    Poynard T, Leroy V, Cohard M, Thevenot T, Methurin P, Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778789.
  • 20
    Hollinger FB, Blatt LM, Tong MJ, Conrad A, Balart L, Pockros P, Bonkovsky VHL, et al. Differential response to treatment with consensus interferon (CIFN) and IFN-α 2b in chronic HCV patients infected with genotype 1a and 1b [Abstract]. Gastroenterology 1996; 110: A1213.
  • 21
    Houghton M. Hepatitis C viruses. In: FieldsBN, KnipeDM, HowleyPM, eds. Fields Virology. Volume 1. Ed 3. Philadelphia: Lippinicott-Raven, 1996: 10351058.